Brown Brothers Harriman & Co. »

Tscan Therapeutics shares owned by Brown Brothers Harriman & Co.

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Brown Brothers Harriman & Co. from 13F filings

Historical chart of Brown Brothers Harriman & Co. investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Brown Brothers Harriman & Co. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Brown Brothers Harriman & Co.

Quarter filed Position value Share count Share price at filing
2025-09-30 $260k 143k 1.82
2025-06-30 $207k 143k 1.45
2025-03-31 $197k 143k 1.38
2024-12-31 $435k 143k 3.04
2024-09-30 $712k 143k 4.98
2024-06-30 $445k 76k 5.85

More positions owned by Brown Brothers Harriman & Co.

Microsoft Corp Common Stock (MSFT)
Alphabet Inc-cl C Common Stock (GOOG)
Oracle Corp Common Stock (ORCL)
Ishares Core S&p 500 Etf Common Stock (IVV)
Kla Corp Common Stock (KLAC)
Berkshire Hathaway Inc-cl B Common Stock (BRK.B)
Apple Common Stock (AAPL)
Mastercard Inc - A Common Stock (MA)
Amazon.com Common Stock (AMZN)
Waste Management Common Stock (WM)
Linde Common Stock (LIN)
Booking Holdings Common Stock (BKNG)
Arthur J Gallagher & Co Common Stock (AJG)
Nvidia Corp Common Stock (NVDA)
Zoetis Common Stock (ZTS)

View all positions for Brown Brothers Harriman & Co.

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
BVF
Baker Bros. Advisors
BlackRock
Vanguard Group
Propel Bio Management
Standard Life Aberdeen
Deer Management
Alphabet
Simplify Asset Management
Morgan Stanley
Renaissance Technologies
DC Funds
Tang Capital Management
Geode Capital Management

View all funds holding Tscan Therapeutics